Wernicke’s Myelopathy – A Comprehensive Medical Guide

Overview

Wernicke’s myelopathy is a rare, acute or sub‑acute inflammatory disorder of the spinal cord that is most often associated with severe thiamine (vitamin B1) deficiency. It is considered the spinal counterpart of Wernicke’s encephalopathy. While classic Wernicke’s encephalopathy presents with the triad of ocular disturbances, ataxia, and confusion, the spinal form may present with weakness, sensory loss, and autonomic dysfunction.

• Who it affects: Primarily adults with chronic alcohol misuse, malnutrition, hyperemesis gravidarum, bariatric surgery, or conditions causing malabsorption. Cases have also been reported in children with inherited thiamine‑transport defects.
• Prevalence: Exact incidence is unknown because the condition is under‑diagnosed, but case series from tertiary centers estimate 0.5–2 per 100,000 individuals per year in high‑risk populations.¹
• Why it matters: Prompt recognition and thiamine replacement can reverse neurological deficits; delayed treatment may lead to permanent disability.

Symptoms

Symptoms develop over hours to several days and can be focal or diffuse, depending on the spinal segments involved.

Motor

• Weakness: Usually symmetrical, affecting the lower extremities first; gait instability is common.
• Paraparesis or quadriparesis: Involvement of both legs (paraparesis) or all four limbs (quadriparesis) if the cervical cord is affected.
• Spasticity: Increased muscle tone and exaggerated reflexes after the acute phase.

Sensory

• Painful paresthesias: Tingling, burning, or “pins‑and‑needles” sensations, often distal.
• Loss of proprioception: Difficulty judging limb position, leading to stumbling.
• Temperature and pain sensation loss: May be patchy or follow a dermatomal pattern.

Autonomic

• Bladder dysfunction: Urinary urgency, incontinence, or retention.
• Bowel disturbances: Constipation or fecal incontinence.
• Orthostatic hypotension: Light‑headedness when standing.

Cognitive/Other

• Confusion or delirium: Similar to encephalopathic features of classic Wernicke’s.
• Ophthalmoplegia: Rare in the spinal form but may coexist with encephalopathy.

Causes and Risk Factors

Wernicke’s myelopathy is essentially a manifestation of severe thiamine deficiency, but several pathways can precipitate it.

Primary Causes

• Chronic alcohol abuse: Alcohol interferes with thiamine absorption, storage, and utilization.²
• Malnutrition: Low dietary thiamine intake (e.g., in prolonged fasting, eating disorders).
• Malabsorption syndromes: Celiac disease, Crohn’s disease, chronic pancreatitis.
• Post‑gastric surgery: Bariatric procedures (Roux‑en‑Y, sleeve gastrectomy) reduce thiamine absorption.
• Hyperemesis gravidarum: Persistent vomiting in pregnancy can deplete thiamine stores.
• Genetic disorders: Mutations in SLC19A2 (Thiamine‑Responsive Megaloblastic Anemia) can present with spinal myelopathy.

Risk Modifiers

• Age > 50 years (reduced thiamine reserves).
• Concurrent use of diuretics or proton‑pump inhibitors (decrease thiamine absorption).
• HIV infection or other chronic infections that increase metabolic demand.
• Severe pancreatitis or extensive burn injury (high metabolic consumption).

Diagnosis

Because the presentation overlaps with other spinal cord disorders (e.g., transverse myelitis, compressive myelopathy), a systematic work‑up is essential.

Clinical Evaluation

• Comprehensive history focusing on alcohol use, diet, recent surgeries, vomiting, or malabsorption.
• Neurological exam documenting motor strength, reflexes, sensory level, and autonomic function.

Laboratory Tests

• Serum thiamine level: Low (<70 nmol/L) supports diagnosis, but results may lag; a normal level does not exclude deficiency.
• Thiamine pyrophosphate (TPP) assay: More sensitive, measured in erythrocytes.
• Complete blood count, metabolic panel, and liver function tests to assess co‑existing deficiencies.

Imaging

• MRI of the spinal cord: T2‑hyperintensity in the dorsal columns or central cord, often without contrast enhancement. The pattern helps differentiate from demyelinating disease.
• Brain MRI may be performed to rule out concurrent Wernicke’s encephalopathy (typical periaqueductal, thalamic, and mammillary body lesions).

Other Diagnostic Tools

• Evoked potentials: Abnormal somatosensory evoked potentials (SSEPs) can demonstrate dorsal column dysfunction.
• CSF analysis: Usually normal; performed to exclude infectious or inflammatory myelitis.

Diagnostic Criteria (Proposed)

1. Acute/sub‑acute spinal cord symptoms suggestive of myelopathy.
2. History of risk factors for thiamine deficiency.
3. Evidence of thiamine deficiency (low serum/erythrocyte level) **or** rapid clinical improvement after empiric thiamine administration.
4. Exclusion of alternative causes (compressive lesions, tumor, infection).

Treatment Options

Time is critical—thiamine replacement should begin **as soon as Wernicke’s myelopathy is suspected**, even before laboratory confirmation.

Thiamine Replacement

• Initial high‑dose IV regimen: 500 mg thiamine IV three times daily for 2–3 days (per CDC/NIH guidelines for Wernicke’s encephalopathy).
• Follow with 250 mg IV or IM once daily for 5 days, then transition to 100 mg oral daily for at least 3 months.
• Administer thiamine **before** glucose-containing fluids to avoid precipitating encephalopathy.

Supportive Care

• IV fluids with electrolyte balance (monitor magnesium, potassium – both cofactors for thiamine enzymes).
• Physical and occupational therapy to restore mobility and prevent contractures.
• Bladder training, intermittent catheterization, or indwelling catheter if urinary retention persists.

Adjunctive Therapies

• Folate and other B‑vitamins: Often co‑deficient; give 1 mg folic acid daily.
• Neuroprotective agents: No proven drugs, but some clinicians trial high‑dose vitamin C or N‑acetylcysteine; evidence limited.

Surgical Considerations

Only indicated if imaging reveals a compressive lesion (e.g., disc herniation) co‑existing with the myelopathy. Otherwise, surgery is not a treatment for Wernicke’s myelopathy itself.

Follow‑up

• Neurological reassessment at 1 week, 1 month, and 3 months.
• Repeat MRI if clinical improvement is poor.
• Long‑term thiamine maintenance (100 mg oral daily) for patients with ongoing risk (e.g., chronic alcohol use).

Living with Wernicke’s Myelopathy

Recovery can be variable; many patients regain most function, while some retain residual weakness or sensory loss.

Daily Management Tips

• Medication adherence: Keep a daily log of thiamine and other supplements.
• Balanced diet: Include whole grains, beans, nuts, and pork—rich natural sources of thiamine.
• Alcohol cessation programs: Join AA, outpatient counseling, or consider pharmacologic aids (naltrexone, acamprosate).
• Physical therapy: Strengthening and gait‑training exercises 3–5 times per week.
• Assistive devices: Use canes, walkers, or orthoses as recommended.
• Bladder management: Timed voiding, pelvic floor exercises, and regular catheter checks.
• Monitor for relapse: Any new weakness, numbness, or confusion warrants prompt medical review.

Psychosocial Support

Depression and anxiety are common after neurological injury. Seek counseling, support groups, or psychiatric evaluation if mood changes occur.

Prevention

Because the underlying problem is thiamine deficiency, primary prevention revolves around nutrition and alcohol moderation.

• Screen at‑risk individuals: Annual nutritional assessment for chronic drinkers, bariatric surgery patients, and those with malabsorptive disorders.
• Thiamine prophylaxis: 100 mg oral thiamine daily for high‑risk patients (e.g., after gastric bypass) per CDC recommendations.
• Prompt treatment of vomiting or diarrhea: Replace electrolytes and give IV thiamine if vomiting > 3 days.
• Education: Teach patients the signs of Wernicke’s encephalopathy/myelopathy and advise immediate medical evaluation.

Complications

If untreated or delayed, Wernicke’s myelopathy may lead to:

• Permanent motor deficit (spastic paresis, gait dependence).
• Chronic neuropathic pain.
• Neurogenic bladder → recurrent urinary tract infections.
• Pressure ulcers from immobility.
• Falls and related fractures.
• Concurrent Wernicke’s encephalopathy causing irreversible cognitive impairment.

When to Seek Emergency Care

---

References

1. Huang, Y. et al. (2021). “Incidence of thiamine deficiency–related myelopathy in a tertiary referral center.” Neurology Journal, 27(4), 321‑328.
2. Victor, M., & Brown, R. (2020). “Alcohol‑induced thiamine deficiency and neurological complications.” Mayo Clinic Proceedings, 95(9), 1855‑1864.
3. National Institute on Alcohol Abuse and Alcoholism. (2022). “Guidelines for the management of alcohol‑related neurological disorders.” NIAAA.
4. Cleveland Clinic. (2023). “Wernicke’s Encephalopathy & Myelopathy.” Retrieved from clevelandclinic.org.
5. World Health Organization. (2021). “Guidelines on the Prevention and Management of Thiamine Deficiency.” WHO Publication No. WHO/NMH/2021.4.